![](/imgs/covers/jp_cover.jpg)
|
Journal of Postgraduate Medicine
Medknow Publications and Staff Society of Seth GS Medical College and KEM Hospital, Mumbai, India
ISSN: 0022-3859 EISSN: 0022-3859
Vol. 53, No. 2, 2007, pp. 135-138
|
Bioline Code: jp07047
Full paper language: English
Document type: Research Article
Document available free of charge
|
|
Journal of Postgraduate Medicine, Vol. 53, No. 2, 2007, pp. 135-138
en |
Drug Review - Exemestane: A milestone against breast cancer
Shetty, YC; Chakkarwar, PN; Acharya, SS & Rajadhyaksha, VD
Abstract
Rapid advances in the treatment of breast cancer, especially in the form of hormone therapy have truly increased the hope of longer and better disease-free survival for these patients. Exemestane, a third generation aromatase inhibitor has been extensively evaluated in metastatic as well as adjuvant therapy of breast cancer. It has also been evaluated for its safety profile, especially on bone and lipids. Exemestane provides hope to the patients with breast cancer both in early and metastatic disease. This review analyzes all the aspects of exemestane therapy.
Keywords
Aromatase inhibitors, breast cancer, hormonal therapy
|
|
© Copyright 2007 Journal of Postgraduate Medicine. Alternative site location: http://www.jpgmonline.com
|
|